Nintedanib for treating idiopathic pulmonary fibrosis

Equality Impact Assessment (Guidance development) (PDF 242 KB)

Final appraisal determination

Final appraisal determination document (PDF 200 KB)

Committee papers (PDF 1.32 MB)

Appraisal consultation

Appraisal consultation document (PDF 196 KB)

Committee papers information

Committee papers (PDF 8.06 MB)

Final scope (PDF 98 KB)

Final matrix (PDF 94 KB)

NICEs response to comments on the draft scope and provisional matrix (PDF 161 KB)

Equality impact assessment (PDF 63 KB)

Idiopathic pulmonary fibrosis - nintedanib: draft scope (pre-referral) - June 2014 (PDF 135 KB)

Idiopathic pulmonary fibrosis - nintedanib: provisional matrix (pre-referral) - June 2014 (PDF 96 KB)